These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11900244)

  • 1. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.
    Olsen O
    Cancer; 2002 Jan; 94(2):578-9; author reply 581-3. PubMed ID: 11900244
    [No Abstract]   [Full Text] [Related]  

  • 2. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.
    Kopans DB
    Cancer; 2002 Jan; 94(2):580-1; author reply 581-3. PubMed ID: 11900247
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.
    Ponzone R; Sismondi P; Baum M
    Cancer; 2002 Jan; 94(2):579-80; author reply 581-3. PubMed ID: 11900246
    [No Abstract]   [Full Text] [Related]  

  • 4. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.
    Gøtzsche PC
    Cancer; 2002 Jan; 94(2):578; author reply 581-3. PubMed ID: 11900245
    [No Abstract]   [Full Text] [Related]  

  • 5. [Novel data on mammography: invitation to organized mammographic screening substantially reduces breast carcinoma mortality].
    Schulz-Wendtland R
    Strahlenther Onkol; 2002 Jan; 178(1):52. PubMed ID: 11977394
    [No Abstract]   [Full Text] [Related]  

  • 6. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.
    Tabár L; Vitak B; Chen HH; Yen MF; Duffy SW; Smith RA
    Cancer; 2001 May; 91(9):1724-31. PubMed ID: 11335897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods to identify benefit from mammographic screening of women aged 40-49 years.
    Feig SA
    Radiology; 1996 Nov; 201(2):309-16. PubMed ID: 8888216
    [No Abstract]   [Full Text] [Related]  

  • 8. The randomized trials of breast cancer screening: what have we learned?
    Smith RA; Duffy SW; Gabe R; Tabar L; Yen AM; Chen TH
    Radiol Clin North Am; 2004 Sep; 42(5):793-806, v. PubMed ID: 15337416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammographic screening for breast cancer: few new data.
    Prescrire Int; 2008 Feb; 17(93):24-7. PubMed ID: 18383654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
    Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
    Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to Kopans.
    Elwood JM; Cox B; Richardson AK
    Online J Curr Clin Trials; 1993 Mar; Doc No 43():[1183 words; 9 paragraphs]. PubMed ID: 8306002
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment on the Elwood Paper.
    Kopans DB
    Online J Curr Clin Trials; 1993 Mar; Doc No 42():[1687 words; 8 paragraphs]. PubMed ID: 8117361
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pros and cons of early cancer detection in breast carcinoma].
    Callies R; Oberhoff C
    MMW Fortschr Med; 2005 Apr; 147(14):30-2. PubMed ID: 15887680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rejoinder to Elwood's reply.
    Kopans DB
    Online J Curr Clin Trials; 1993 Apr; Doc No 47():[1069 words; 5 paragraphs]. PubMed ID: 8306004
    [No Abstract]   [Full Text] [Related]  

  • 15. [Norwegian breast cancer mortality rates and validity of Swedish mammographic studies].
    Zahl PH; Kopjar B; Maehlen J
    Tidsskr Nor Laegeforen; 2001 Jun; 121(16):1928-31. PubMed ID: 11488185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammographic screening of women aged 40 to 49 years. Is it justified?
    Feig SA
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):587-606. PubMed ID: 7731636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of breast cancer screening by mammography in younger women.
    Elwood JM; Cox B; Richardson AK
    Online J Curr Clin Trials; 1993 Feb; Doc No 32():[23,227 words; 195 paragraphs]. PubMed ID: 8305999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cochrane review on screening for breast cancer with mammography.
    Olsen O; Gøtzsche PC
    Lancet; 2001 Oct; 358(9290):1340-2. PubMed ID: 11684218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does organized mammographic screening reduce breast cancer mortality? The Cancer Registry's view on the current debate].
    Wang H; Hofvind S; Tretli S; Thoresen S; Langmark F
    Tidsskr Nor Laegeforen; 2002 Jan; 122(2):211-3. PubMed ID: 11873583
    [No Abstract]   [Full Text] [Related]  

  • 20. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.